Drugs / Biochaperone Combo
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02915250 | Oct 2016 → Jun 2017 | type 2 diabetes mellitus | Adocia | Completed | No outcome recorded |
| Phase 1 | NCT02514954 | Jul → Nov 2015 | type 1 diabetes mellitus | Adocia | Completed | No outcome recorded |
| Phase 1 | NCT02514850 | Jul → Nov 2015 | type 2 diabetes mellitus | Adocia | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Biochaperone Combo | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02514954 ↗ |
| Route | Subcutaneous | “single subcutaneous doses of 0.8 U/kg Biochaperone® Combo” NCT02514850 ↗ |